Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 424 | 403 | 392 | 452 | 446 |
| Accounts receivable | -53 | 506 | 345 | -776 | 1,979 |
| Other Working Capital | 3,538 | 1,765 | 391 | -908 | 210 |
| Other Operating Activity | -30,875 | -31,122 | -24,483 | -21,202 | -24,704 |
| Operating Cash Flow | $-26,966 | $-28,448 | $-23,355 | $-22,434 | $-22,068 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -239 | -8 | -55 | -286 | -29 |
| Purchase Of Investment | 0 | 0 | -20,348 | N/A | N/A |
| Sale Of Investment | 0 | 20,230 | N/A | N/A | N/A |
| Investing Cash Flow | $-239 | $20,222 | $-20,403 | $-286 | $-29 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -348 | -407 | -381 | -366 | -461 |
| Common Stock Issued | 6,919 | 31,620 | 12,574 | 32,912 | 38,296 |
| Other Financing Activity | 65 | 781 | 12 | 469 | 1,938 |
| Financing Cash Flow | $6,636 | $31,994 | $12,205 | $33,016 | $39,774 |
| Exchange Rate Effect | 1,599 | -522 | 1,957 | -253 | -605 |
| Beginning Cash Position | 34,912 | 11,666 | 41,262 | 31,220 | 14,148 |
| End Cash Position | 15,942 | 34,912 | 11,666 | 41,262 | 31,220 |
| Net Cash Flow | $-20,569 | $23,768 | $-31,553 | $10,296 | $17,676 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,966 | -28,448 | -23,355 | -22,434 | -22,068 |
| Capital Expenditure | -239 | -8 | -55 | -286 | -29 |
| Free Cash Flow | -27,205 | -28,456 | -23,410 | -22,720 | -22,098 |